Evidence map›Paper›PMID 41254152›Full record

ArticleScientific reports2025

Evidence for a severe cognitive subgroup in a comprehensive neuropsychological Post-COVID-19 syndrome classification.

Luisa T Balz, Deborah K Erhart, Ingo Uttner, Dorothée E Lulé, Hayrettin Tumani

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Luisa T BalzDepartment of Neurology, Faculty of Medicine, Ulm University Oberer Eselsberg, 45-89071, Ulm, Germany.ORCID http://orcid.org/0009-0002-8088-3386
Deborah K ErhartDepartment of Neurology, Faculty of Medicine, Ulm University Oberer Eselsberg, 45-89071, Ulm, Germany.ORCID http://orcid.org/0000-0002-3003-4119
Ingo UttnerDepartment of Neurology, Faculty of Medicine, Ulm University Oberer Eselsberg, 45-89071, Ulm, Germany.
Dorothée E Lulé *Department of Neurology, Faculty of Medicine, Ulm University Oberer Eselsberg, 45-89071, Ulm, Germany. dorothee.lule@uni-ulm.de.ORCID http://orcid.org/0000-0001-5944-398X
Hayrettin Tumani *Department of Neurology, Faculty of Medicine, Ulm University Oberer Eselsberg, 45-89071, Ulm, Germany.ORCID http://orcid.org/0000-0002-1647-6201

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 7% of adults develop Post-COVID-19 syndrome (PCS). Cognitive impairment is common, but its profile in PCS is not well defined and requires clearer differentiation from general (post-)illness effects. The aim of this study was to identify distinct cognitive profiles in PCS and to characterize them with respect to broader psychological factors such as fatigue, depression, anxiety, and personality. To this end, we assessed cognition, fatigue, depression, anxiety, and personality traits in PCS patients, convalescents (CV), healthy controls (HC), and post-viral syndrome patients (PV) of different etiology. Cognitive performance was assessed with an extensive protocol covering multiple cognitive domains, including verbal and nonverbal short-term memory, verbal and nonverbal working memory, verbal and nonverbal episodic memory, visuoconstruction, attentional functions, and executive functions, alongside patient-reported measures of fatigue, depression, anxiety, and personality, as well as self-reported information on lifetime psychiatric diagnoses. Group comparisons and discriminant analysis (p = .065) identified the tests that best differentiate the groups, while exploratory cluster analysis allowed for data-driven group assignment. In this study, N = 54 PCS, N = 42 HC, N = 25 CV, and N = 12 PV were included. Patients with PCS show low mean scores and cluster into two subgroups: 7.5% with severe objective cognitive impairments (PCS

Indexed as

Cognitive DysfunctionCOVID-19AdultAnxietyCase-Control StudiesCognitionDepressionFatigueFemaleHumansMaleMiddle AgedNeuropsychological TestsPost-Acute COVID-19 SyndromeSARS-CoV-2Cluster analysisFatigueMood disordersNeuropsychological testsPost-COVID-19 syndrome

Identifiers

PMID41254152
PMCPMC12627843

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.